Product Information

TRANEXAMIC ACID 650 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.8567 per EA under NDC 00591372030. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 27, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRANEXAMIC ACID 650 MG TABLET

Tranexamic Acid
$0.8567per EA

Strength

650 mg/1

NDC

00591372030

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TRANEXAMIC ACID

Approval Type

Generic (ANDA)

FDA Application

ANDA202093

FDA Approved

12/27/2012

TE Code

AB

On Market Since

1/3/2013

Pharmacological Classes

Antifibrinolytic Agent
Decreased Fibrinolysis

Price Statistics

The NADAC for TRANEXAMIC ACID 650 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 76.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.8567 per EA
All-time high$4.0347 (Mar 12, 2014)
All-time low$0.8442 (Jul 22, 2026)
52-week high$1.0267
52-week low$0.8442
Median price$2.1846
Average price$2.2339
Largest weekly change-36.1% (Nov 20, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+1.5%

1M

+1.5%

3M

-4.3%

6M

-15.1%

1Y

-14.9%

3Y

-38.6%

5Y

-63.2%

All

-76.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TRANEXAMIC ACID 650 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRANEXAMIC ACID 650 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.8567 per EA (NDC 00591372030), effective Aug 19, 2026.

How has the price of TRANEXAMIC ACID 650 MG TABLET changed over time?

Over the history we have for it, the NADAC for TRANEXAMIC ACID 650 MG TABLET has declined 76.0%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TRANEXAMIC ACID 650 MG TABLET?

Since Nov 28, 2013, the NADAC for TRANEXAMIC ACID 650 MG TABLET has ranged from a low of $0.8442 (Jul 22, 2026) to a high of $4.0347 (Mar 12, 2014), with a median of $2.1846 per EA.

Are there cheaper alternatives to TRANEXAMIC ACID 650 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TRANEXAMIC ACID 650 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TRANEXAMIC ACID 650 MG TABLET?

TRANEXAMIC ACID 650 MG TABLET (NDC 00591372030) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.